Locations:
Search IconSearch

Research

20-NEU-1918414-alzheimer-brain-650×450

Studies of an Alpha-1 Adrenergic Agonist for Alzheimer’s Advance With New NIA Grant

$2 million will enable preclinical dose and efficacy testing of “compound 3”

EEG monitoring
June 30, 2020/COVID-19

Continuous EEG Monitoring Reveals Seizures, Other Abnormalities in COVID-19 Patients

Acute symptomatic seizures detected in five of 22 patients monitored

Older man with cane
June 11, 2020/Neurosciences/Research

New Study Indicates Neurological Function Deteriorates Quicker in Depressed MS Patients

Depressed patients also have increased odds for new brain lesions on MRI

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

brain MRI showing central vein sign
June 4, 2020/Neurosciences/Research

Central Vein Sign: Large Study Is Launched to Establish a New Diagnostic Biomarker in MS

Researchers hope it will lead to earlier, more accurate diagnosis

20-NEU-1892170-ischemic-stroke-650×450

Research on tPA Nanoconjugate Aims to Extend Thrombolysis Benefits to More Stroke Patients

$2M NIH grant will help see if dual-action agent lengthens treatment window

20-NEU-1882508_CQD_650x450_combined

Thalamus Is a Prime Target for Neurodegeneration in MS, Study Suggests

Researchers pair postmortem MRI with histopathology to explore thalamic atrophy

20-NEU-1867295-reoperative-epilepsy-surgery_650x450
March 31, 2020/Neurosciences/Research

Long-Term Outcomes of Repeat Epilepsy Surgery: Insights from the Largest Study to Date

Odds of seizure freedom diminish with each additional operation

mobile stroke unit
March 16, 2020/Neurosciences/Research

Mobile Stroke Units: Economically Superior to Standard Transport When Thresholds Are Achieved

Study compares financial impacts of clinical and geographic factors

19-NEU-6036-genetics-650×450
February 27, 2020/Cancer

NSCLC Patients with Brain Metastases: Look to Molecular Data for Prognostication

Number of brain metastases doesn’t matter for ALK/EGFR+ patients

BackPage 5 of 13Next

Advertisement

Ad